Showing results (91-100 of 2,744) with videos related to

Sort By:
Pageof 275
Clinical and Experimental Nephrology|October 14, 2004
Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetesToshiki Moriyama, Kazumasa Oka, Hirotsugu Ueda, et al.
Clinical and Experimental Nephrology|October 14, 2004
A male patient with steroid-dependent nephrotic syndrome for 25 years and obesity-associated focal segmental glomerulosclerosisOsamu Motoyama, Atsuhiko Muto, Hidetaka Ogiwara, et al.
Clinical and Experimental Nephrology|October 14, 2004
Steroid-sensitive nephrotic syndrome associated with positive C1q immunofluorescenceSeiji Hashimoto, Yayoi Ogawa, Takashi Ishida, et al.
Clinical and Experimental Nephrology|October 14, 2004
Granulomatous interstitial nephritis due to isolated renal sarcoidosisKen-ichi Miyoshi, Takafumi Okura, Seiko Manabe, et al.
Clinical and Experimental Nephrology|October 14, 2004
Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathyItsuro Kazama, Mitsunobu Matsubara, Mari Michimata, et al.
Clinical and Experimental Nephrology|October 31, 2003
Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamicsShuji Arima
Clinical and Experimental Nephrology|October 31, 2003
Roles of bone marrow cells in glomerular diseasesToshiyuki Imasawa
Clinical and Experimental Nephrology|October 31, 2003
The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cellsYonghui Mao, Tetsuya Ootaka, Takao Saito, et al.
Clinical and Experimental Nephrology|October 31, 2003
Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathyAtsuhisa Sato, Mitsuhisa Tabata, Koichi Hayashi, et al.
Clinical and Experimental Nephrology|October 31, 2003
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) StudyYasuhiko Iino, Matsuhiko Hayashi, Tetsuya Kawamura, et al.
Pageof 275